| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SYNLOGIC, INC. | Director | Stock Option (right to buy) | 30,000 | 22 Jun 2023 | Direct | ||
| Eiger BioPharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 28,000 | 01 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SYBX | SYNLOGIC, INC. | 22 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 14:21 |
| /report/000114036123010159-kelly-croswell-lisa-2023-03-01 | Eiger BioPharmaceuticals, Inc. | 01 Mar 2023 | 1 | $0 | 4 | Director | 03 Mar 2023, 19:49 |
| /report/000156761922014201-kelly-croswell-lisa-2022-07-18 | Eiger BioPharmaceuticals, Inc. | 18 Jul 2022 | 1 | $0 | 4 | Director | 19 Jul 2022, 19:02 |
| /report/000156761922014200-kelly-croswell-lisa-2022-07-18 | Eiger BioPharmaceuticals, Inc. | 18 Jul 2022 | 0 | $0 | 3 | Director | 19 Jul 2022, 18:58 |
| SYBX | SYNLOGIC, INC. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:15 |
| SYBX | SYNLOGIC, INC. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 17:11 |